Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study (NCT07245667)
Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis
🩺 Plain-English Summary (8th-Grade Level)
This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).
Who can join: Review the eligibility criteria below.
Location: Kuchnir Dermatology and Dermatological Surgery — Framingham, Massachusetts
Age range: 16 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Kuchnir Dermatology and Dermatological Surgery — Framingham, Massachusetts
- Kuchnir Dermatology and Dermatological Surgery — Milford, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 869-0126
Email: cschanbacher@propedix.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Tinea Pedis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.